SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
Autor: | Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | International Journal of Molecular Sciences, Vol 21, Iss 9, p 3377 (2020) |
Druh dokumentu: | article |
ISSN: | 21093377 1422-0067 1661-6596 |
DOI: | 10.3390/ijms21093377 |
Popis: | The current pandemic coronavirus, SARS-CoV-2, is a global health emergency because of its highly contagious nature, the great number of patients requiring intensive care therapy, and the high fatality rate. In the absence of specific antiviral drugs, passive prophylaxis, or a vaccine, the treatment aim in these patients is to prevent the potent virus-induced inflammatory stimuli from leading to the acute respiratory distress syndrome (ARDS), which has a severe prognosis. Here, the mechanism of action and the rationale for employing immunological strategies, which range from traditional chemically synthesized drugs, anti-cytokine antibodies, human immunoglobulin for intravenous use, to vaccines, are reviewed. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |